stockrow
Friday 6 November 2026
Export HTFL’s income statement to Excel — free account
Heartflow, Inc.
HTFL Healthcare Health Information Services
Heartflow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.0 million, up 39.9% from fiscal 2024.
- Revenue
- +47.6%
- EPS
- +87.7%
- Free cash flow
- +62.6%
Quarter to June 2026, against a year earlier
52.48
0.53
+1.02%
Follow HTFL
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+7 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
10.21 | 6.10 | 10.89 | 11.95 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(558.99) | (101.39) | (69.21) | (295.55) | |
P/B ratio |
6.49 | 3.57 | 7.29 | 9.06 | |
Price to Tangible BV |
6.49 | 3.57 | 7.29 | 9.06 | |
EV/Sales |
9.54 | 6.13 | 11.01 | 12.05 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(26.87) | (19.99) | (29.70) | (48.91) | |
EV/FCF |
(25.35) | (18.29) | (27.45) | (43.17) | |
Quick Ratio |
8.43 | 4.87 | 5.10 | 4.66 | |
Current Ratio |
8.66 | 5.20 | 5.57 | 5.08 | |
Net Debt/EBITDA |
25.52 | 10.29 | 5.67 | 10.01 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.59 | 0.74 | 0.72 | 0.84 | |
Operating CF/Net income |
0.06 | 0.43 | 1.10 | 0.54 | |
Capex/Depreciation |
(0.33) | (3.33) | (1.18) | (1.16) | |
Interest Coverage |
(4.38) | (2,218.75) | (9,834.67) | — | |
Research and Development Expense of Revenue |
37.38% | 37.99% | 41.11% | 40.98% | |
Selling, General and Administrative Expense of Revenue |
71.78% | 77.65% | 80.94% | 69.96% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
8.56% | 10.71% | 12.46% | 12.35% | |
Graham Net Nets |
0.13 | 0.15 | 0.07 | 0.06 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(39.83%) | (27.57%) | (12.78%) | (6.24%) | |
Free Cash Flow Yield |
(3.69%) | (5.50%) | (3.68%) | (2.33%) | |
Revenue per Share |
0.94 | 1.33 | 0.61 | 0.74 | |
Operating CF per Share |
(0.06) | (0.29) | (0.35) | (0.10) | |
Capex per Share |
(0.03) | (0.05) | (0.02) | (0.02) | |
Free Cash Flow per Share |
(0.09) | (0.34) | (0.37) | (0.12) | |
Cash per Share |
5.93 | 4.80 | 1.85 | 1.88 | |
Shareholders Equity per Share |
5.18 | 8.16 | 3.34 | 3.24 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
5.18 | 8.16 | 3.34 | 3.24 | |
Free Cash Flow |
(4.19) | (12.49) | (31.99) | (10.50) | |
Working Capital |
289.94 | 177.83 | 173.81 | 179.88 | |
Capital Expenditures |
(1.23) | (1.90) | (1.89) | (1.92) | |
Net Current Asset Value |
217.96 | 161.40 | 153.52 | 159.23 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.04 | 0.04 | 0.03 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
24.20 | 26.99 | 31.92 | 36.22 | |
Average Payables |
2.42 | 3.02 | 3.86 | 3.36 | |
Average Assets |
274.72 | 239.08 | 264.23 | 251.91 | |
Average Common Equity |
(261.50) | (279.42) | (301.64) | (307.53) |
Columns are period end dates · fundamentals updated 25 Oct 2026